Andrew Feinberg Less Quotations

We've long suspected that genomic changes underlie cancer risk, but that knowledge hasn't translated yet into a broadly applicable way to identify individuals most at risk. The BRCA1 and BRCA2 genes implicated in breast and ovarian cancers are great examples, but they are applicable only to a small percentage -- less than one percent -- of women.